SBIO vs. SPY
Compare and contrast key facts about ALPS Medical Breakthroughs ETF (SBIO) and SPDR S&P 500 ETF (SPY).
SBIO and SPY are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. SBIO is a passively managed fund by SS&C that tracks the performance of the S-Network Medical Breakthroughs Index. It was launched on Dec 31, 2014. SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993. Both SBIO and SPY are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SBIO or SPY.
Correlation
The correlation between SBIO and SPY is 0.54, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
SBIO vs. SPY - Performance Comparison
Key characteristics
SBIO:
0.45
SPY:
2.21
SBIO:
0.82
SPY:
2.93
SBIO:
1.10
SPY:
1.41
SBIO:
0.26
SPY:
3.26
SBIO:
1.45
SPY:
14.40
SBIO:
9.12%
SPY:
1.90%
SBIO:
29.14%
SPY:
12.44%
SBIO:
-63.06%
SPY:
-55.19%
SBIO:
-44.86%
SPY:
-1.83%
Returns By Period
In the year-to-date period, SBIO achieves a 6.26% return, which is significantly lower than SPY's 26.72% return.
SBIO
6.26%
-8.53%
3.70%
9.38%
-4.31%
N/A
SPY
26.72%
0.20%
10.28%
27.17%
14.87%
13.04%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SBIO vs. SPY - Expense Ratio Comparison
SBIO has a 0.50% expense ratio, which is higher than SPY's 0.09% expense ratio.
Risk-Adjusted Performance
SBIO vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SBIO vs. SPY - Dividend Comparison
SBIO's dividend yield for the trailing twelve months is around 3.47%, more than SPY's 1.19% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SBIO ALPS Medical Breakthroughs ETF | 3.47% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.19% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% | 1.81% |
Drawdowns
SBIO vs. SPY - Drawdown Comparison
The maximum SBIO drawdown since its inception was -63.06%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for SBIO and SPY. For additional features, visit the drawdowns tool.
Volatility
SBIO vs. SPY - Volatility Comparison
ALPS Medical Breakthroughs ETF (SBIO) has a higher volatility of 9.70% compared to SPDR S&P 500 ETF (SPY) at 3.83%. This indicates that SBIO's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.